Pnc Financial Services Group, Inc. Cabaletta Bio, Inc. Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$7.22 - $18.82 $303 - $790	-42 Reduced 8.06%	479 $3,000
Q1 2024 May 10, 2024	SELL	$16.79 - $25.38 $2,837 - $4,289	-169 Reduced 24.49%	521 $8,000
Q4 2023 Feb 09, 2024	SELL	$12.21 - $23.36 $1,172 - $2,242	-96 Reduced 12.21%	690 $15,000
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $852 - $1,342	72 Added 10.08%	786 $11,000
Q2 2023 Aug 11, 2023	BUY	$7.65 - $13.95 $1,055 - $1,925	138 Added 23.96%	714 $9,000
Q1 2023 May 15, 2023	BUY	$7.08 - $12.62 $4,078 - $7,269	576 New	576 $4,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $62.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.